An implanted shunt diverts CSF from the ventricles within the brain or the subarachnoid spaces around the brain and spinal cord to another body region where it will be absorbed. This creates an alternative route for removal of CSF which is constantly produced within the brain and usually restores the physiological balance between CSF production, flow, and absorption when one or more of these functions has been impaired. Valves contained within the shunt pathway act like on-off switches, opening when the differential pressure (DP) – i.e., the pressure difference across the valve – exceeds the valve’s opening pressure. Valves are either set to a fixed pressure or they can be adjustable from outside the body. Accessory devices may be added to the shunt to modify valve function.

Market Analysis and Insights: Global and United States Ventriculoperitoneal (VP) Shunt Market
This report focuses on global and United States Ventriculoperitoneal (VP) Shunt market.
In 2020, the global Ventriculoperitoneal (VP) Shunt market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In United States the Ventriculoperitoneal (VP) Shunt market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Ventriculoperitoneal (VP) Shunt Scope and Market Size
Ventriculoperitoneal (VP) Shunt market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Ventriculoperitoneal (VP) Shunt market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Ventriculoperitoneal (VP) Shunt market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
Fixed Pressure Valves
Variable Pressure Valves

Segment by Application
Hospitals
Clinics and Ambulatory Care centers
Laboratories
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Sophysa
Aesculap
B. Braun Melsungen
Integra lifesciences
Medtronic